Inflammatory damage on respiratory and nervous systems due to hRSV infection

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 14-21

  Bohmwald, Karen ^a   Espinoza, Janyra A ^a   Becerra, Daniela ^a   Rivera, Katherine ^a   Lay, Margarita K ^a   Bueno, Susan M ^a,c   Riedel, Claudia A ^a   Kalergis, Alexis M ^a,b,c  

^a Pontificia Universidad Católica de Chile   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN ANTIBODY; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE;

BACTERIAL MENINGITIS; BRAIN DISEASE; COGNITIVE DEFECT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOCOMPETENT CELL; NERVOUS SYSTEM INFLAMMATION; NEUROTROPISM; NONHUMAN; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SEIZURE; VIRAL CLEARANCE; VIRUS IMMUNITY; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; LUNG; METABOLISM; NERVOUS SYSTEM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; VIROLOGY;

ANIMALS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INFLAMMATION MEDIATORS; LUNG; NERVOUS SYSTEM; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY SYSTEM;

EID: 84930210520     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.05.003     Document Type: Review

References (53)

1. Espinoza J.A., Bohmwald K., Cespedes P.F., Riedel C.A., Bueno S.M., Kalergis A.M. Modulation of host adaptive immunity by hRSV proteins. Virulence 2014, 5:740-751.
2. Feng J., Hu Y., Song Z., Liu Y., Guo X., Jie Z. Interleukin-23 facilitates th1 and th2 cell differentiation in vitro following respiratory syncytial virus infection. J Med Virol 2015, 87:708-715.
3. Aujard Y., Fauroux B. Risk factors for severe respiratory syncytial virus infection in infants. Respir Med 2002, 96(Suppl B):S9-S14.
4. Resch B. Burden of respiratory syncytial virus infection in young children. World J Clin Pediatr 2012, 1:8-12.
5. Guo-Parke H., Canning P., Douglas I., Villenave R., Heaney L.G., Coyle P.V., Lyons J.D., Shields M.D., Power U.F. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 2013, 188:842-851.
6. Pickles R.J., DeVincenzo J.P. Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. J Pathol 2015, 235:266-276.
7. Chen Y.W., Huang Y.C., Ho T.H., Huang C.G., Tsao K.C., Lin T.Y. Viral etiology of bronchiolitis among pediatric in patients in northern Taiwan with emphasis on newly identified respiratory viruses. J Microbiol Immunol Infect 2014, 47:116-121.
8. Hayashi S., Hogg J.C. Adenovirus infections and lung disease. Curr Opin Pharmacol 2007, 7:237-243.
9. Herold S., Becker C., Ridge K.M., Budinger G.R. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 2015, 45:1463-1478.
10. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection-a systematic review. Crit Care 2006, 10:R107.
11. Morichi S., Kawashima H., Ioi H., Yamanaka G., Kashiwagi Y., Hoshika A., Nakayama T., Watanabe Y. Classification of acute encephalopathy in respiratory syncytial virus infection. J Infect Chemother 2011, 17:776-781.
12. Webster D.L., Gardner A.H., Dye T.J., Chima R.S. Status epilepticus: a possible association with human metapneumovirus infection. Pediatrics 2014, 133:e747-e750.
13. Goenka A., Michael B.D., Ledger E., Hart I.J., Absoud M., Chow G., Lilleker J., Lunn M., McKee D., Peake D., et al. Neurological manifestations of influenza infection in children and adults: results of a national British surveillance study. Clin Infect Dis 2014, 58:775-784.
14. Niizuma T., Okumura A., Kinoshita K., Shimizu T. Acute encephalopathy associated with human metapneumovirus infection. Jpn J Infect Dis 2014, 67:213-215.
15. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008, 6:114-124.
16. Bohmwald K., Espinoza J.A., Gonzalez P.A., Bueno S.M., Riedel C.A., Kalergis A.M. Central nervous system alterations caused by infection with the human respiratory syncytial virus. Rev Med Virol 2014, 24:407-419.
17. Huang Y.C., Huang S.L., Chen S.P., Huang Y.L., Huang C.G., Tsao K.C., Lin T.Y. Adenovirus infection associated with central nervous system dysfunction in children. J Clin Virol 2013, 57:300-304.
18. Ioannidis I., McNally B., Willette M., Peeples M.E., Chaussabel D., Durbin J.E., Ramilo O., Mejias A., Flano E. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 2012, 86:5422-5436.
19. Persson B.D., Jaffe A.B., Fearns R., Danahay H. Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLoS One 2014, 9:e102368.
20. Openshaw P.J. Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proc Am Thorac Soc 2005, 2:121-125.
21. Villenave R., Thavagnanam S., Sarlang S., Parker J., Douglas I., Skibinski G., Heaney L.G., McKaigue J.P., Coyle P.V., Shields M.D., et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci U S A 2012, 109:5040-5045.
22. Espinoza J.A., Bueno S.M., Riedel C.A., Kalergis A.M. Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design. Immunology 2014, 143:1-12.
23. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., et al. Pattern recognition receptors tlr4 and cd14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401.
24. Zeng R., Cui Y., Hai Y., Liu Y. Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines. Virus Res 2012, 167:138-145.
25. Moreno-Solis G., Torres-Borrego J., de la Torre-Aguilar M.J., Fernandez-Gutierrez F., Llorente-Cantarero F.J., Perez-Navero J.L. Analysis of the local and systemic inflammatory response in hospitalized infants with respiratory syncitial virus bronchiolitis. Allergol Immunopathol (Madr) 2014, 10.1016/j.aller.2014.02.002.
26. Goritzka M., Durant L.R., Pereira C., Salek-Ardakani S., Openshaw P.J., Johansson C. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol 2014, 88:6128-6136.
27. Durbin R.K., Kotenko S.V., Durbin J.E. Interferon induction and function at the mucosal surface. Immunol Rev 2013, 255:25-39.
28. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14:778-809. table of contents.
29. Marr N., Wang T.I., Kam S.H., Hu Y.S., Sharma A.A., Lam A., Markowski J., Solimano A., Lavoie P.M., Turvey S.E. Attenuation of respiratory syncytial virus-induced and rig-i-dependent type i ifn responses in human neonates and very young children. J Immunol 2014, 192:948-957.
30. Lai S.H., Liao S.L., Wong K.S., Lin T.Y. Defective innate immune responses to respiratory syncytial virus infection in ovalbumin-sensitized mice. J Microbiol Immunol Infect 2014, 10.1016/j.jmii.2014.09.001.
31. Selvaggi C., Pierangeli A., Fabiani M., Spano L., Nicolai A., Papoff P., Moretti C., Midulla F., Antonelli G., Scagnolari C. Interferon lambda 1-3 expression in infants hospitalized for rsv or hrv associated bronchiolitis. J Infect 2014, 68:467-477.
32. Sommereyns C., Paul S., Staeheli P., Michiels T. Ifn-lambda (ifn-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008, 4:e1000017.
33. Segovia J., Sabbah A., Mgbemena V., Tsai S.Y., Chang T.H., Berton M.T., Morris I.R., Allen I.C., Ting J.P., Bose S. Tlr2/myd88/nf-kappab pathway, reactive oxygen species, potassium efflux activates nlrp3/asc inflammasome during respiratory syncytial virus infection. PLoS One 2012, 7:e29695.
34. Triantafilou K., Kar S., Vakakis E., Kotecha S., Triantafilou M. Human respiratory syncytial virus viroporin sh: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 2013, 68:66-75.
35. Gomez R.S., Guisle-Marsollier I., Bohmwald K., Bueno S.M., Kalergis A.M. Respiratory syncytial virus: pathology, therapeutic drugs and prophylaxis. Immunol Lett 2014, 162:237-247.
36. de Almeida Nagata D.E., Demoor T., Ptaschinski C., Ting H.A., Jang S., Reed M., Mukherjee S., Lukacs N.W. Il-27r-mediated regulation of il-17 controls the development of respiratory syncytial virus-associated pathogenesis. Am J Pathol 2014, 184:1807-1818.
37. Lambert S.L., Aslam S., Stillman E., MacPhail M., Nelson C., Ro B., Sweetwood R., Lei Y.M., Woo J.C., Tang R.S. A novel respiratory syncytial virus (RSV) f subunit vaccine adjuvanted with gla-se elicits robust protective th1-type humoral and cellular immunity in rodent models. PLoS One 2015, 10:e0119509.
38. Schauer U., Hoffjan S., Rothoeft T., Bartz H., Konig S., Fuchs E., Bittscheidt J., Kochling A., Stephan V. Severe respiratory syncytial virus infections and reduced interferon-gamma generation in vitro. Clin Exp Immunol 2004, 138:102-109.
39. Faber T.E., Groen H., Welfing M., Jansen K.J., Bont L.J. Specific increase in local il-17 production during recovery from primary rsv bronchiolitis. J Med Virol 2012, 84:1084-1088.
40. Gaffen S.L. Structure and signalling in the il-17 receptor family. Nat Rev Immunol 2009, 9:556-567.
41. Stoppelenburg A.J., de Roock S., Hennus M.P., Bont L., Boes M. Elevated th17 response in infants undergoing respiratory viral infection. Am J Pathol 2014, 184:1274-1279.
42. Mukherjee S., Lindell D.M., Berlin A.A., Morris S.B., Shanley T.P., Hershenson M.B., Lukacs N.W. Il-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011, 179:248-258.
43. Lotz M.T., Peebles R.S. Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr Allergy Asthma Rep 2012, 12:380-387.
44. Monick M.M., Powers L.S., Hassan I., Groskreutz D., Yarovinsky T.O., Barrett C.W., Castilow E.M., Tifrea D., Varga S.M., Hunninghake G.W. Respiratory syncytial virus synergizes with th2 cytokines to induce optimal levels of tarc/ccl17. J Immunol 2007, 179:1648-1658.
45. Tapia L.I., Ampuero S., Palomino M.A., Luchsinger V., Aguilar N., Ayarza E., Mamani R., Larranaga C. Respiratory syncytial virus infection and recurrent wheezing in Chilean infants: a genetic background?. Infect Genet Evol 2013, 16:54-61.
46. Castilow E.M., Meyerholz D.K., Varga S.M. Il-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J Immunol 2008, 180:2376-2384.
47. Puthothu B., Krueger M., Forster J., Heinzmann A. Association between severe respiratory syncytial virus infection and il13/il4 haplotypes. J Infect Dis 2006, 193:438-441.
48. Kawashima H., Kashiwagi Y., Ioi H., Morichi S., Oana S., Yamanaka G., Takekuma K., Hoshika A., Sawai J., Kato Y. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J Infect Chemother 2012, 18:827-831.
49. Espinoza J.A., Bohmwald K., Cespedes P.F., Gomez R.S., Riquelme S.A., Cortes C.M., Valenzuela J.A., Sandoval R.A., Pancetti F.C., Bueno S.M., et al. Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci U S A 2013, 110:9112-9117.
50. Huang S.H., Jong A.Y. Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier. Cell Microbiol 2001, 3:277-287.
51. Li X.Q., Fu Z.F., Alvarez R., Henderson C., Tripp R.A. Respiratory syncytial virus (rsv) infects neuronal cells and processes that innervate the lung by a process involving rsv g protein. J Virol 2006, 80:537-540.
52. Shakeri A., Mastrangelo P., Griffin J.K., Moraes T.J., Hegele R.G. Respiratory syncytial virus receptor expression in the mouse and viral tropism. Histol Histopathol 2015, 30:401-411.
53. Jang H., Boltz D., Sturm-Ramirez K., Shepherd K.R., Jiao Y., Webster R., Smeyne R.J. Highly pathogenic h5n1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A 2009, 106:14063-14068.